General Mills disappointed the market this week (20 December) when the US group lowered its full-year revenue outlook on the back of a 7.1% drop in sales during its second quarter. The company's aggressive cost-cutting programmes enabled it to maintain its margin guidance but, Katy Askew asks, is the group's weak top line evidence management has cut spending in certain areas too deeply?